Chronic gynaecological pain is a major medical problem that affects 20-30% of women at different moments of their life. This largely neglected issue has a significant impact on the sexual and conjugal life of women suffering from it as well as on their psychological health. Furthermore, this kind of pain is not well understood, often misdiagnosed or even totally ignored. Also, treatment is limited and not extensively studied. This study aims at better understanding and treating gynaecological pain. The focus of the study will be provoked vestibulodynia, pain at the entry of the vagina. The efficacy of specialized pelvic floor physiotherapy will be compared to a topical cream (lidocaine) applied to the vulva. The treatment efficacy will be assessed in 234 women (aged from 18-45 years old) suffering from provoked vestibulodynia recruited in 4 hospitals (CHUS, Jewish General Hospital, Royal-Victoria Hospital, CHUM St-Luc).
This is a randomised controlled trial comparing the impact of multimodal physiotherapy treatments to topical lidocaine in women suffering from provoked vestibulodyina. The first treatment consists of 10 sixty minutes weekly physiotherapy treatments including relaxation techniques, stretching and pelvic floor muscle control exercises. The second treatment is a night time application of lidocaine to the vulva for 10 weeks. Physiotherapists will then evaluate women's pain and sexual function right after the treatment and 6 months later.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
212
10 weeks of weekly physiotherapy treatments including relaxation techniques, stretching and pelvic floor muscle control exercises.
10 weeks of daily topical 5% lidocaine application
University of Montreal
Montreal, Quebec, Canada
Centre Hospitalier Universitaire de Sherbrooke
Sherbrooke, Quebec, Canada
Change in pain during intercourse
evaluated with a visual analog scale
Time frame: before treatment, after treatment, 6 months after treatment
Change in global sexual function
evaluated with the female sexual function index (FSFI)
Time frame: before treatment, after treatment, 6 months after treatment
Change in pain catastrophizing
evaluated using the pain catastrophizing scale
Time frame: before treatment, after treatment, 6 months after treatment
Change in psychologic distress
evaluated using the State-trait Anxiety Inventory (STAI)
Time frame: before treatment, after treatment, 6 months after treatment
Change in fear of pain
evaluated using the Pain Anxiety Symptoms Scale (PASS-20)
Time frame: before treatment, after treatment, 6 months after treatment
Change in vulvar blood circulation
evaluated using a doppler laser
Time frame: before treatment, after treatment, 6 months after treatment
Change in pelvic floor muscles function
evaluated using transperineal ultrasound and dynamometry
Time frame: before treatment, after treatment, 6 months after treatment
Change in pain sensitivity (pressure pain)
evaluated using a vulvagesiometer
Time frame: before treatment, after treatment, 6 months after treatment
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.